Search results for "PLASMA"

showing 10 items of 4043 documents

Vitamin D kinetics in the acute phase of critical illness: A prospective observational study.

2017

Abstract Purpose The objective of this study was to assess the vitamin D kinetics in critically ill patients by performing periodic serum vitamin D measurements in short time intervals in the initial phase of a critical illness. Materials and methods We performed vitamin D serum measurements: at admission and then in 12-hour time intervals. The minimum number of vitamin D measurements was 4, and the maximum was 8 per patient. Results A total of 363 patients were evaluated for participation, and 20 met the inclusion criteria. All patients had an initial serum vitamin D level between 10.6 and 39 ng/mL. Nineteen patients had vitamin D levels between 10 and 30 ng/mL, which means that they had v…

AdultMalemedicine.medical_specialtyCritical IllnessCritical Care and Intensive Care MedicineGastroenterologyvitamin D deficiency03 medical and health sciencesPlasma0302 clinical medicineIntensive careInternal medicineSeverity of illnessmedicineVitamin D and neurologyHumans030212 general & internal medicineProspective StudiesVitamin DProspective cohort studyAgedbusiness.industryDiagnostic Tests Routine030208 emergency & critical care medicineMiddle Agedmedicine.diseaseVitamin D DeficiencySurgeryHospitalizationInitial phaseCritical illnessAcute DiseaseObservational studyFemalebusinessJournal of critical care
researchProduct

Serum levels of substance P are decreased in patients with type 1 diabetes.

2000

Morphological and immunohistochemical studies in diabetic subjects have shown a depletion of the neuropeptide substance P (SP) in the central and peripheral nervous system. This is the first study investigating serum levels of substance P in type 1 diabetes patients (n=50) and controls (n=75) by means of an enzyme immunoassay. The serum level of SP was significantly decreased in the diabetic group compared to the control group (10.12+/-0.29 vs. 12.25+/-0.38 pg/ml; p<0.0001). In diabetic patients, there was no correlation of substance P levels with age, serum creatinine, albuminuria, total cholesterol, HDL- or LDL-cholesterol, triglycerides, HbA1c, type or duration of diabetes and gender. Fu…

AdultMalemedicine.medical_specialtyDiabetic neuropathyAdolescentEndocrinology Diabetes and MetabolismSubstance PSubstance PImmunoenzyme Techniqueschemistry.chemical_compoundEndocrinologyReference ValuesInternal medicineDiabetes mellitusBlood plasmaInternal MedicinemedicineHumansAgedType 1 diabetesCreatininebusiness.industryGeneral MedicineMiddle Agedmedicine.diseasePeripheral neuropathyEndocrinologyCholesterolDiabetes Mellitus Type 1chemistryAlbuminuriaFemalemedicine.symptombusinessExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Dose-response relationships and plasma concentrations of digitalis glycosides in man.

1978

An inter-individual, randomized, double-blind study of digitoxin (Dt) and β-acetyl digoxin (D) was performed in 120 healthy male volunteers. Groups of 10 persons each received orally D 0, 0.1, 0.2, 0.3, 0.4, 0.5 or 0.6 mg and Dt 0.04, 0.08, 0.12, or 0.16 mg daily for 7 days; Loading doses were given for the first three days. Plasma levels were measured with an86Rb-erythrocyte assay 24 h after the last dose. ECG, carotid artery pulse and phonocardiogram were recorded prior to (b) and 24 h after (a) the last dose. QTc, amplitude of T-waves in V2 to V6, electromechanical systole (QS2c) and left ventricular ejection time (LVETc) were measured. The differences between a and b (Δ-values) reflect …

AdultMalemedicine.medical_specialtyDigoxinTime FactorsDigoxinDigitoxinQT intervalElectrocardiographyDigitoxinDouble-Blind MethodInternal medicinemedicineHumansPharmacology (medical)Pharmacologychemistry.chemical_classificationClinical Trials as TopicDose-Response Relationship DrugChemistryPulse (signal processing)GlycosideDigitalis GlycosidesHeartGeneral MedicinePlasma levelsEndocrinologySystolic time intervalsPlasma concentrationmedicine.drugEuropean journal of clinical pharmacology
researchProduct

Insulin, renin-aldosterone system and blood pressure in obese people.

2001

OBJECTIVE: To evaluate the relationship between insulin, the renin-aldosterone system and blood pressure in obese subjects. DESIGN AND METHODS: A cross sectional study of a group of severely obese normotensive subjects who were surgical candidates (n=39; mean BMI: 47.8±1.4) and a group of hypertensive patients (n=57; mean BMI: 28.0±0.7) twenty-nine of whom had BMI>27. All subjects were studied after 15 days on a balanced diet. Insulin, plasma renin activity and aldosterone were measured. RESULTS: Fasting insulin, plasma renin activity and aldosterone were higher in severely obese normotensive subjects than in hypertensive subjects (respectively 32.3±3.0 vs 13.1±1.0 mU/l, P=0.0001; 1.34±0.22…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)Blood PressurePlasma renin activityRenin-Angiotensin Systemchemistry.chemical_compoundInternal medicineHyperinsulinismRenin–angiotensin systemBlood plasmaReninmedicineHyperinsulinemiaHumansInsulinObesityAldosteroneNutrition and DieteticsAldosteronebusiness.industryInsulinMiddle Agedmedicine.diseaseObesity MorbidEndocrinologyBlood pressureCross-Sectional StudieschemistryHypertensionFemalebusinessHyperinsulinismInternational journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
researchProduct

Behaviour of nitric oxide metabolites in unprofessional athletes before and after a cardiopulmonary test.

2010

Physical training causes an increase in nitric oxide (NO) production [2, 3, 8, 9] and this datum explains the link between exercise and endothelium and seems to demonstrate how regular training upregulates eNOS expression, although it is not sure if this upregulation is due to shear stress or metabolic factors [3]. However, it must be underlined that besides to be directly influenced by exogenous NO, erythrocytes express a functional NOS [5, 6, 11, 13] that raises the circulation NO pool. The literature data describe that an 8-week exercise training induced an increase in plasma levels of NO metabolites (NOx), that persisted four weeks after interruption of training [8]. A similar trend was…

AdultMalemedicine.medical_specialtyEndotheliumPhysiologyNitric OxideNitric oxidechemistry.chemical_compoundEnosPhysiology (medical)Internal medicinemedicineHumansnitrite nitrate exerciseNitritesNitratesPhysical Education and Trainingbiologybusiness.industryAthletesHematologyPlasma levelsNitric oxide metabolismbiology.organism_classificationEndocrinologymedicine.anatomical_structurechemistryAthletesAnesthesiaFemaleCardiology and Cardiovascular MedicinebusinessCardiopulmonary testClinical hemorheology and microcirculation
researchProduct

Plasma catecholamine responses and neural adaptation during short-term resistance training

2000

Low exercise-induced plasma adrenaline (A) responses have been reported in resistance-trained indi- viduals. In the study reported here, we investigated the interaction between strength gain and neural adaptation of the muscles, and the plasma A response in eight healthy men during a short-term resistance-training period. The subjects performed 5 resistance exercises (E1-E5), consisting of 6 sets of 12 bilateral leg exten- sions performed at a 50% load, and with 2 days rest in between. Average electromyographic (EMG) signal amplitude was recorded before and after the exercises, from the knee extensor muscles in isometric maximal voluntary contraction (MVC) as well as during the exercises (a…

AdultMalemedicine.medical_specialtyEpinephrineKnee JointPhysiologyPhysical exerciseIsometric exerciseElectromyographyNorepinephrineOxygen ConsumptionIsometric ContractionPhysiology (medical)Internal medicineStatistical significanceBlood plasmamedicineHumansOrthopedics and Sports MedicineLactic AcidMuscle SkeletalExerciseLegmedicine.diagnostic_testElectromyographybusiness.industryNeural adaptationPublic Health Environmental and Occupational HealthGeneral MedicineAdaptation PhysiologicalSurgerymedicine.anatomical_structureEndocrinologyCatecholaminemedicine.symptombusinessmedicine.drugMuscle contractionEuropean Journal of Applied Physiology
researchProduct

Cerebral abscesses imaging: A practical approach

2020

Abstract: Brain abscesses (BAs) are focal infections of the central nervous system (CNS) that start as a localised area of weakening of the brain parenchyma (cerebritis) and develops into a collection of pus surrounded by a capsule. Pyogenic (bacterial) BAs represent the majority of all BAs; in some cases, the diagnostic and therapeutic management can be challenging. Imaging has a primary role in differentiating BAs from other lesions. Conventional magnetic resonance imaging (cMRI) is essential for the identification of the lesion, its localisation and its morphological features. However, cMRI does not allow to reliably differentiate BAs from other intracranial mass lesions such as necrotic…

AdultMalemedicine.medical_specialtyFeverCerebral AbscesseseducationCentral nervous systemBrain Abscess030218 nuclear medicine & medical imagingDiagnosis DifferentialLesionYoung Adult03 medical and health sciences0302 clinical medicineMagnetic resonance spectroscopy (MRS)Brain absceBrain Injuries TraumaticParenchymamedicineHumansMagnetic resonance imaging (MRI)Brain abscessAgedDiffusion weighted imaging (DWI)medicine.diagnostic_testbusiness.industryPharmacology. TherapyHeadacheMagnetic resonance imagingMycobacterium tuberculosisMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAspergillusmedicine.anatomical_structurePositron-Emission TomographyCerebritisFemaleRadiologyDifferential diagnosismedicine.symptombusinessToxoplasma030217 neurology & neurosurgeryJournal of Population Therapeutics &amp; Clinical Pharmacology
researchProduct

Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer

2012

Cancer-related disseminated intravascular coagulation (DIC) is a life-threatening condition for which no effective treatment is currently available. Protein C (PC), a modulator of coagulation as well as the inflammatory system, has been successfully tested (in its activated recombinant form [a-rPC]) in sepsis-related coagulopathy, but with an increased risk for major bleeding. Plasma-derived PC (pd-PC) is more suitable than a-rPC in patients at high risk from bleeding due to its self-limiting process. We carried out a single-arm study evaluating the role of pd-PC in adult cancer patients with overt DIC. Over a period of 3 years, we treated 19 patients with overt DIC and a PC plasma concentr…

AdultMalemedicine.medical_specialtyGastroenterologySettore MED/15 - Malattie Del SangueNeoplasmsInternal medicineCoagulopathymedicineHumansBlood Coagulationdisseminated intravascular coagulationSurvival analysisAgedAged 80 and overDisseminated intravascular coagulationHematologic Testsbusiness.industryPlasma derivedAnticoagulantsCancerHematologyMiddle Agedmedicine.diseaseSurvival AnalysisThrombosisSurgeryCoagulationFemalebusinessProtein CProtein Cmedicine.drugAmerican Journal of Hematology
researchProduct

Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence

2002

Abnormalities in monoamine neurotransmission have been implicated in the pathogenesis of alcoholism, mood disorders and schizophrenia. Murine norepinephrine transporter gene (NET) has been mapped to a region on chromosome 8 where a quantitative trait locus for ethanol sensitivity. Therefore we tested whether norepinephrine transporter (NET) gene variants confer susceptibility to either alcohol dependence or severe alcohol withdrawal symptoms. There is a highly polymorphic silent G1287A mutation in the NET gene. In our study 157 alcoholics and 185 healthy unrelated matched control subjects were analyzed for a silent G1287A mutation. No significant differences in allele and genotype distribut…

AdultMalemedicine.medical_specialtyGenotypeDNA Mutational AnalysisMolecular Sequence DataAlcohol Withdrawal DeliriumGene FrequencyPolymorphism (computer science)Internal medicineGenotypemedicineHumansGenetic Predisposition to DiseaseRNA MessengerAlleleAllelesBiological PsychiatryGeneticsNorepinephrine Plasma Membrane Transport ProteinsPolymorphism GeneticSymportersbiologybusiness.industryAlcohol dependenceExonsMiddle Agedmedicine.diseaseAlcoholismPsychiatry and Mental healthMonoamine neurotransmitterEndocrinologyMood disordersNorepinephrine transporterbiology.proteinFemaleGene polymorphismbusinessPolymorphism Restriction Fragment LengthPsychiatry Research
researchProduct

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1.

2008

Retinol-binding protein 4 (RBP4) is an adipocytokine associated with insulin resistance (IR). We tested serum levels of RBP4 to assess its link with steatosis in patients with genotype 1 chronic hepatitis C (CHC) or nonalcoholic fatty liver disease (NAFLD). Nondiabetic patients with CHC (n = 143) or NAFLD (n = 37) were evaluated by liver biopsy and anthropometric and metabolic measurements, including IR by the homeostasis model assessment. Biopsies were scored by Scheuer classification for CHC, and Kleiner for NAFLD. Steatosis was tested as a continuous variable and graded as absent-mild &lt;30%, or moderate-severe &gt; or =30%. Thirty nondiabetic, nonobese blood donors served as controls. …

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusSettore MED/08 - Anatomia Patologicamedicine.disease_causeGastroenterologySeverity of Illness IndexInsulin resistanceRisk FactorsInternal medicineNonalcoholic fatty liver diseasemedicinesteatosisHumansRetinol-binding protein 4 .Retinol binding protein 4Settore MED/12 - GastroenterologiaHepatologybiologymedicine.diagnostic_testOdds ratioHepatologyHepatitis C ChronicMiddle Agedmedicine.diseaseFatty LiverLogistic ModelsLiverLiver biopsyImmunologybiology.proteinFemaleSteatosisRetinol-Binding Proteins PlasmaBiomarkers
researchProduct